Pubfacts - Scientific Publication Data
  • Categories
  • Journals
  • ->
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:
Get 20% Off Journals at LWW.com

An Integrated Framework for Reducing Hospital Readmissions using Risk Trajectories Characterization and Discharge Timing Optimization.

Authors:
Adel Alaeddini Jonathan E Helm Pengyi Shi Syed Hasib Akhter Faruqui

IISE Trans Healthc Syst Eng 2019 19;9(2):172-185. Epub 2019 Apr 19.

Department of Mechanical Engineering, University of Texas at San Antonio, San Antonio, TX-78249.

When patients leave the hospital for lower levels of care, they experience a risk of adverse events on a daily basis. The advent of value-based purchasing among other major initiatives has led to an increasing emphasis on reducing the occurrences of these post-discharge adverse events. This has spurred the development of new prediction technologies to identify which patients are at risk for an adverse event as well as actions to mitigate those risks. Those actions include pre-discharge and post-discharge interventions to reduce risk. However, traditional prediction models have been developed to support only post-discharge actions; predicting risk of adverse events at the time of discharge only. In this paper we develop an integrated framework of risk prediction and discharge optimization that supports both types of interventions: discharge timing and post-discharge monitoring. Our method combines a kernel approach for capturing the non-linear relationship between length of stay and risk of an adverse event, with a Principle Component Analysis method that makes the resulting estimation tractable. We then demonstrate how this prediction model could be used to support both types of interventions by developing a simple and easily implementable discharge timing optimization.

Download full-text PDF

Source
http://dx.doi.org/10.1080/24725579.2019.1584133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822616PMC
April 2019

Publication Analysis

Top Keywords

risk adverse
16
adverse events
12
discharge timing
12
adverse event
8
integrated framework
8
types interventions
8
timing optimization
8
risk
7
adverse
5
discharge
5
post-discharge interventions
4
stay risk
4
pre-discharge post-discharge
4
include pre-discharge
4
actions include
4
interventions reduce
4
reduce risk
4
traditional prediction
4
risk traditional
4
length stay
4

Similar Publications

Impact of Frailty and Ultrasonography-Based Sarcopenia on the Development of Postoperative Complications in Gastrointestinal Cancer Patients.

Authors:
GÖzde ŞengÜl AyÇİÇek TİmuÇİn Erol Pelİn Ünsal Olgun Denİz Osman AbbasoĞlu Meltem GÜlhan Halİl

Turk J Med Sci 2021 Feb 26. Epub 2021 Feb 26.

Background: Gastrointestinal (GI) system cancers are common among older adults and it is still difficult to predict which are at increased risk for postoperative complications. Frailty and sarcopenia are increasing problems of older population and may be associated with adverse outcomes. In this study we aimed to examine the impact of frailty and sarcopenia on postoperative complications in older patients undergoing surgery for GI cancers. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Belimumab for systemic lupus erythematosus.

Authors:
Jasvinder A Singh Nipam P Shah Amy S Mudano

Cochrane Database Syst Rev 2021 Feb 25;2:CD010668. Epub 2021 Feb 25.

Department of Medicine - Rheumatology, University of Alabama at Birmingham, Birmingham, USA.

Background: Belimumab, the first biologic approved for the treatment of systemic lupus erythematosus (SLE), has been shown to reduce autoantibody levels in people with SLE and help control disease activity.

Objectives: To assess the benefits and harms of belimumab (alone or in combination) in systematic lupus erythematosus.

Search Methods: An Information Specialist carried out the searches of CENTRAL, MEDLINE, Embase, CINAHL, Web of Science, the World Health Organization (WHO) International Clinical Trials Registry Platform, and clinicaltrials. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option.

Authors:
Matthew M Rusgis Afaq Y Alabbasi Leigh Anne Nelson

Am J Health Syst Pharm 2021 Feb 26. Epub 2021 Feb 26.

University of Missouri-Kansas School of Pharmacy, Kansas City, MO, USA.

Disclaimer: In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview.

Authors:
Ana I Tabar Julio Delgado Eloina González-Mancebo Esozia Arroabarren Lorena Soto Retes Javier Domínguez-Ortega

Int Arch Allergy Immunol 2021 Feb 25:1-19. Epub 2021 Feb 25.

Department of Allergy, La Paz Hospital Institute for Health Research (IdiPAZ), CIBER of Respiratory Diseases, CIBERES, Madrid, Spain.

The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Per- and polyfluoroalkyl substances and calcifications of the coronary and aortic arteries in adults with prediabetes: Results from the diabetes prevention program outcomes study.

Authors:
Citlalli Osorio-Yáñez Marco Sanchez-Guerra Andres Cardenas Pi-I D Lin Russ Hauser Diane R Gold Ken P Kleinman Marie-France Hivert Abby F Fleisch Antonia M Calafat Thomas F Webster Edward S Horton Emily Oken

Environ Int 2021 Feb 22;151:106446. Epub 2021 Feb 22.

Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

Background: Per- and polyfluoroalkyl substances (PFAS) are endocrine disrupting chemicals that have been associated with cardiovascular risk factors including elevated body weight and hypercholesterolemia. Therefore, PFAS may contribute to the development of atherosclerosis and cardiovascular disease (CVD). However, no previous study has evaluated associations between PFAS exposure and arterial calcification. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
Get 20% Off Journals at LWW.com
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap